Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRV120027 adaptive ascending infusion study in heart failure
2010-020376-37Phase 2Completed
- Sponsor
- Trevena, Inc.
- Start
- Jan 2011
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in heart failure (HF) and Acute Heart Failure (AHF) comparing TRV120027 infusion with Placebo infusion (2 arms). Primary endpoint: Safety and tolerability. Started Jan 2011; status: completed.
02
Drugs
TRV120027
03
Conditions
heart failure (HF)Acute Heart Failure (AHF)
Beyond the preview
Go deeper on 2010-020376-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020376-37.